CIK: 0001274403 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 16, 2020
Total Value ($000): $20,032 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | RUBIUS THERAPEUTICS INC | 2,618,351 | $13,118 | 65.5% | $16.08 | — | COM | 78116T103 |
| — | CHIASMA INC | 1,196,776 | $5,146 | 25.7% | $3.11 | — | COM | 16706W102 |
| — | SYROS PHARMACEUTICALS INC | 200,000 | $1,768 | 8.8% | $10.38 | — | COM | 87184Q107 |